Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 10 | 2024 | 5168 | 1.740 |
Why?
|
Coronary Artery Disease | 15 | 2024 | 6567 | 1.630 |
Why?
|
Catheter Ablation | 7 | 2022 | 2776 | 1.580 |
Why?
|
Vitamin K | 3 | 2021 | 314 | 1.250 |
Why?
|
Anticoagulants | 6 | 2024 | 4843 | 1.090 |
Why?
|
Thromboembolism | 2 | 2023 | 1004 | 0.940 |
Why?
|
Primary Prevention | 3 | 2021 | 1187 | 0.820 |
Why?
|
Atherosclerosis | 6 | 2024 | 3431 | 0.770 |
Why?
|
Stroke | 7 | 2023 | 9742 | 0.750 |
Why?
|
Coronary Angiography | 7 | 2024 | 4537 | 0.740 |
Why?
|
Atrial Appendage | 1 | 2023 | 285 | 0.660 |
Why?
|
Plaque, Atherosclerotic | 4 | 2024 | 1548 | 0.600 |
Why?
|
Endocardium | 1 | 2019 | 249 | 0.600 |
Why?
|
Medication Therapy Management | 1 | 2019 | 131 | 0.590 |
Why?
|
Drug-Eluting Stents | 2 | 2022 | 681 | 0.560 |
Why?
|
Bioprosthesis | 1 | 2021 | 592 | 0.560 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2024 | 2763 | 0.560 |
Why?
|
Aspirin | 4 | 2024 | 3135 | 0.520 |
Why?
|
Anticholesteremic Agents | 2 | 2023 | 972 | 0.510 |
Why?
|
Myocardial Infarction | 6 | 2024 | 11516 | 0.510 |
Why?
|
Chagas Cardiomyopathy | 1 | 2015 | 72 | 0.490 |
Why?
|
Pericardium | 1 | 2019 | 679 | 0.470 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2024 | 10377 | 0.460 |
Why?
|
Heart Valve Prosthesis | 3 | 2021 | 1468 | 0.450 |
Why?
|
Tachycardia, Ventricular | 2 | 2019 | 1309 | 0.440 |
Why?
|
Warfarin | 1 | 2021 | 1493 | 0.420 |
Why?
|
Hypercholesterolemia | 2 | 2019 | 1142 | 0.410 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1397 | 0.410 |
Why?
|
Patient Admission | 1 | 2019 | 1367 | 0.400 |
Why?
|
Angioplasty, Balloon | 1 | 2015 | 592 | 0.380 |
Why?
|
Pulmonary Valve | 1 | 2015 | 413 | 0.380 |
Why?
|
Cryosurgery | 1 | 2016 | 477 | 0.370 |
Why?
|
Cardiovascular Diseases | 7 | 2023 | 15649 | 0.370 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 12241 | 0.370 |
Why?
|
Heart-Assist Devices | 1 | 2021 | 1292 | 0.360 |
Why?
|
Pulmonary Veins | 1 | 2016 | 754 | 0.350 |
Why?
|
Coronary Artery Bypass | 2 | 2022 | 2194 | 0.350 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1447 | 0.350 |
Why?
|
Prosthesis Failure | 1 | 2015 | 1208 | 0.350 |
Why?
|
Heart Conduction System | 1 | 2015 | 1009 | 0.340 |
Why?
|
Calcinosis | 3 | 2024 | 1481 | 0.340 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15455 | 0.310 |
Why?
|
Epicardial Mapping | 2 | 2019 | 58 | 0.310 |
Why?
|
Influenza, Human | 1 | 2019 | 1539 | 0.310 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5891 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2024 | 3252 | 0.280 |
Why?
|
Hemorrhage | 5 | 2023 | 3461 | 0.270 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5538 | 0.250 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3438 | 0.250 |
Why?
|
Lipoprotein(a) | 3 | 2024 | 490 | 0.240 |
Why?
|
Aortic Valve Stenosis | 3 | 2022 | 2034 | 0.240 |
Why?
|
Humans | 50 | 2024 | 768393 | 0.240 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2015 | 1568 | 0.240 |
Why?
|
Stents | 2 | 2019 | 3201 | 0.240 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7453 | 0.230 |
Why?
|
Heart Failure | 3 | 2023 | 11858 | 0.230 |
Why?
|
Risk Assessment | 9 | 2024 | 24318 | 0.220 |
Why?
|
Recurrence | 4 | 2022 | 8506 | 0.220 |
Why?
|
Treatment Outcome | 13 | 2024 | 65379 | 0.220 |
Why?
|
Risk Factors | 14 | 2024 | 74962 | 0.210 |
Why?
|
Coronary Vessels | 6 | 2024 | 3125 | 0.200 |
Why?
|
Calcium | 5 | 2024 | 5794 | 0.200 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2023 | 284 | 0.200 |
Why?
|
Fibrinolytic Agents | 2 | 2023 | 2074 | 0.190 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2023 | 152 | 0.190 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9261 | 0.180 |
Why?
|
Catheters | 1 | 2024 | 427 | 0.180 |
Why?
|
Rheumatic Heart Disease | 1 | 2021 | 164 | 0.170 |
Why?
|
Brazil | 2 | 2024 | 1248 | 0.170 |
Why?
|
Action Potentials | 2 | 2019 | 1838 | 0.170 |
Why?
|
Administration, Oral | 2 | 2018 | 4039 | 0.170 |
Why?
|
Diuretics | 1 | 2023 | 612 | 0.170 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 2192 | 0.160 |
Why?
|
Odds Ratio | 3 | 2016 | 9682 | 0.160 |
Why?
|
Matched-Pair Analysis | 1 | 2019 | 286 | 0.160 |
Why?
|
Sympathectomy | 1 | 2019 | 72 | 0.160 |
Why?
|
Hypolipidemic Agents | 2 | 2020 | 609 | 0.160 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2022 | 775 | 0.150 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2022 | 346 | 0.150 |
Why?
|
Blood Transfusion | 1 | 2024 | 1309 | 0.150 |
Why?
|
Aortic Valve | 3 | 2022 | 1969 | 0.140 |
Why?
|
Multiple Organ Failure | 1 | 2019 | 387 | 0.140 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2024 | 1092 | 0.140 |
Why?
|
Brugada Syndrome | 1 | 2018 | 98 | 0.140 |
Why?
|
Chest Pain | 1 | 2023 | 1099 | 0.130 |
Why?
|
Prognosis | 5 | 2024 | 30022 | 0.130 |
Why?
|
Phrenic Nerve | 1 | 2016 | 81 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2024 | 1030 | 0.130 |
Why?
|
Heart Atria | 1 | 2022 | 1360 | 0.130 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2022 | 672 | 0.130 |
Why?
|
Heart Rate | 2 | 2019 | 4218 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 589 | 0.130 |
Why?
|
Cardiac Tamponade | 1 | 2016 | 175 | 0.120 |
Why?
|
Disease Progression | 2 | 2024 | 13646 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2024 | 1335 | 0.120 |
Why?
|
Paralysis | 1 | 2016 | 250 | 0.120 |
Why?
|
Anemia | 1 | 2024 | 1519 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2024 | 1202 | 0.120 |
Why?
|
Middle Aged | 14 | 2024 | 223491 | 0.120 |
Why?
|
Pericardial Effusion | 1 | 2016 | 246 | 0.120 |
Why?
|
Atrial Flutter | 1 | 2016 | 253 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 849 | 0.110 |
Why?
|
Tachycardia, Supraventricular | 1 | 2016 | 273 | 0.110 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 3108 | 0.110 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2398 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1568 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1962 | 0.100 |
Why?
|
Peripheral Arterial Disease | 1 | 2023 | 1303 | 0.100 |
Why?
|
Male | 15 | 2024 | 364902 | 0.090 |
Why?
|
Female | 16 | 2024 | 397089 | 0.090 |
Why?
|
Incidence | 4 | 2024 | 21544 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2024 | 3801 | 0.090 |
Why?
|
Time Factors | 4 | 2024 | 40272 | 0.090 |
Why?
|
Aged | 10 | 2024 | 171562 | 0.080 |
Why?
|
Acute Kidney Injury | 2 | 2019 | 1943 | 0.080 |
Why?
|
Angina Pectoris | 2 | 2024 | 960 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2015 | 2126 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6318 | 0.080 |
Why?
|
Comorbidity | 2 | 2019 | 10588 | 0.070 |
Why?
|
Registries | 1 | 2024 | 8379 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14784 | 0.070 |
Why?
|
Cardiology | 1 | 2019 | 1701 | 0.070 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.070 |
Why?
|
Prevalence | 3 | 2024 | 15872 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3857 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2819 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6856 | 0.060 |
Why?
|
Length of Stay | 1 | 2019 | 6519 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2018 | 3838 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2019 | 5367 | 0.060 |
Why?
|
Adult | 6 | 2024 | 223640 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10844 | 0.060 |
Why?
|
Benzylamines | 1 | 2024 | 251 | 0.050 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2023 | 69 | 0.050 |
Why?
|
Uracil | 1 | 2024 | 210 | 0.050 |
Why?
|
United States | 3 | 2021 | 73150 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20765 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18471 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6409 | 0.050 |
Why?
|
Neprilysin | 1 | 2023 | 487 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1104 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1126 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59686 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2024 | 81801 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1402 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1226 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2024 | 1281 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1066 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2023 | 1517 | 0.030 |
Why?
|
Exercise Test | 1 | 2024 | 2186 | 0.030 |
Why?
|
Up-Regulation | 1 | 2024 | 4142 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2027 | 0.030 |
Why?
|
Coronary Stenosis | 1 | 2019 | 802 | 0.030 |
Why?
|
Renal Replacement Therapy | 1 | 2015 | 283 | 0.030 |
Why?
|
Child, Preschool | 1 | 2015 | 42650 | 0.030 |
Why?
|
Weight Loss | 1 | 2023 | 2713 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5044 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3064 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2023 | 39407 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3728 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12456 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2917 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2015 | 828 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 60049 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2661 | 0.020 |
Why?
|
Child | 1 | 2015 | 80891 | 0.020 |
Why?
|
Adolescent | 1 | 2015 | 89184 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2019 | 2083 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16721 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20224 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12870 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15939 | 0.010 |
Why?
|
Exercise | 1 | 2019 | 5946 | 0.010 |
Why?
|
Diet | 1 | 2019 | 8090 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2019 | 15881 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54920 | 0.010 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_